370
Participants
Start Date
August 1, 2019
Primary Completion Date
August 1, 2026
Study Completion Date
August 1, 2026
Bracketing
At the beginning of therapy, ultrasonographic examination is used to measure the tumor in three dimensions and bracket the tumor using 4-6 metal clips which will serve as markers for the initial tumor extent in case of tumor shrinkage in response to systemic treatment.
Neoadjuvant therapy
All patients will receive primary systemic therapy according to the current institutional guidelines. Drugs include cytotoxic chemotherapy, hormonal therapy and/or anti-HER2/neu therapy as indicated.
Post-treatment volume margin resection
The lumpectomy resection margin is planned according to the identifiable tumor at operation. The initial extent of the tumor at diagnosis is not taken in account. If there is complete clinical response to systemic therapy (i.e. no identifiable tumor), the center of the bracketed tissue is biopsied.
Pre-treatment volume margin resection
The lumpectomy includes the whole bracketed tissue to take in account the initial tumor extent before systemic therapy.
RECRUITING
Mansoura University Oncology Center, Al Mansurah
Mansoura University
OTHER